Cardiovascular Systems is a medical technology company that develops, manufactures, and markets devices to treat vascular diseases. The Company offers peripheral arterial disease products, which are catheter-based platforms for treating a range of plaque types in leg arteries above and below the knee, including calcified plaque, as well as address various limitations associated with surgical, catheter, and pharmacological treatment alternatives. It also provides an atherectomy device for the treatment of calcified coronary arteries.
Type | Public | |
Founded | 1989 | |
HQ | Saint Paul, MN, US | Map |
Website | csi360.com | |
Employee Ratings | More | |
Overall Culture | C- | More |
USD | |
---|---|
Revenue (Q2, 2021) | 64.2m |
Gross profit (Q2, 2021) | 50.2m |
Gross profit margin (Q2, 2021), % | 78.3% |
Net income (Q2, 2021) | (56.0k) |
EBIT (Q2, 2021) | 283.0k |
Market capitalization (8-Feb-2021) | 1.7b |
Closing stock price (8-Feb-2021) | 42.7 |
Cash (31-Dec-2020) | 73.8m |
USD | Q1, 2012 | Q2, 2012 | Q3, 2012 | Q1, 2013 | Q2, 2013 | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q2, 2021 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 18.7m | 19.7m | 21.2m | 23.3m | 25.3m | 26.5m | 29.8m | 32.3m | 34.9m | 41.4m | 44.7m | 47.0m | 43.9m | 41.4m | 44.5m | 49.8m | 50.0m | 52.1m | 49.7m | 52.6m | 55.6m | 56.3m | 60.2m | 63.3m | 64.5m | 68.3m | 61.2m | 64.2m |
Cost of goods sold | 4.3m | 4.6m | 5.1m | 5.3m | 6.0m | 6.2m | 6.9m | 7.3m | 7.7m | 8.9m | 9.3m | 10.4m | 8.8m | 8.1m | 8.7m | 9.5m | 9.2m | 11.1m | 9.2m | 9.5m | 10.0m | 10.6m | 11.5m | 12.2m | 12.7m | 13.7m | 12.2m | 13.9m |
Gross profit | 14.3m | 15.2m | 16.1m | 18.0m | 19.4m | 20.2m | 22.9m | 25.0m | 27.2m | 32.5m | 35.4m | 36.6m | 35.1m | 33.3m | 35.7m | 40.3m | 40.9m | 41.0m | 40.5m | 43.1m | 45.6m | 45.7m | 48.7m | 51.1m | 51.8m | 54.6m | 49.0m | 50.2m |
Gross profit Margin, % | 77% | 77% | 76% | 77% | 76% | 76% | 77% | 77% | 78% | 79% | 79% | 78% | 80% | 81% | 80% | 81% | 82% | 79% | 81% | 82% | 82% | 81% | 81% | 81% | 80% | 80% | 80% | 78% |
USD | Q1, 2012 | Q2, 2012 | Q3, 2012 | Q1, 2013 | Q2, 2013 | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q2, 2021 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash | 22.7m | 24.6m | 22.5m | 32.2m | 29.2m | 69.9m | 63.2m | 146.7m | 146.0m | 116.4m | 101.3m | 93.5m | 76.7m | 65.3m | 62.2m | 58.2m | 79.3m | 103.1m | 104.7m | 107.3m | 109.3m | 113.4m | 118.8m | 115.3m | 58.9m | 65.5m | 69.6m | 73.8m |
Accounts Receivable | 11.8m | 12.5m | 13.0m | 13.5m | 13.0m | 15.2m | 15.3m | 15.9m | 19.5m | 22.4m | 26.1m | 31.2m | 26.9m | 25.8m | 23.0m | 24.3m | 25.4m | 27.9m | 27.3m | 27.9m | 31.9m | 30.3m | 29.9m | 35.0m | 34.6m | 35.8m | 30.9m | 32.5m |
Prepaid Expenses | 1.2m | 1.4m | 980.0k | 1.2m | 1.1m | 778.0k | 1.5m | 1.0m | 3.6m | 4.1m | 3.9m | 2.6m | 1.6m | 1.4m | 2.0m | 1.4m | 3.5m | 6.0m | 2.6m | 2.4m | 2.2m | 1.9m | 2.2m | 2.9m | 3.0m | 2.2m | 3.0m | |
Inventories | 7.1m | 8.0m | 7.8m | 7.0m | 7.2m | 6.8m | 8.3m | 10.3m | 11.9m | 14.6m | 14.0m | 13.2m | 15.4m | 18.2m | 18.2m | 16.9m | 16.2m | 16.6m | 17.0m | 17.4m | 17.0m | 18.1m | 19.7m | 19.3m | 19.5m | 21.5m | 24.1m | 32.5m |
USD | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 |
---|---|---|---|---|---|---|---|---|---|
Net Income | (16.8m) | (24.0m) | (35.3m) | (32.8m) | (56.0m) | (1.8m) | 1.7m | (255.0k) | (27.2m) |
Depreciation and Amortization | 55.0k | 70.0k | 124.0k | 171.0k | 3.9m | 4.1m | 3.9m | 3.4m | 4.2m |
Inventories | (1.2m) | 818.0k | (6.6m) | (1.1m) | (3.5m) | 543.0k | 292.0k | (1.5m) | (9.6m) |
Accounts Payable | 269.0k | 1.5m | 4.6m | 581.0k | (970.0k) | 1.8m | 104.0k | 566.0k | 576.0k |
USD | Q1, 2012 | Q2, 2012 | Q3, 2012 | Q1, 2013 | Q2, 2013 | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q2, 2021 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | (3.9m) | (8.0m) | (12.2m) | (5.2m) | (11.0m) | (17.2m) | (7.3m) | (15.9m) | (25.7m) | (8.2m) | (13.5m) | (24.2m) | (13.3m) | (28.4m) | (51.1m) | (1.9m) | (815.0k) | (2.6m) | (2.0m) | (2.4m) | (2.0m) | (2.9m) | (2.4m) | (1.7m) | (5.8m) | (9.2m) | (12.1m) | (2.1m) |
Depreciation and Amortization | 40.0k | 144.0k | 293.0k | 102.0k | 138.0k | 408.0k | 833.0k | 1.4m | 973.0k | 2.0m | 2.9m | 1.8m | 2.8m | 3.8m | 1.0m | 2.1m | 3.6m | 854.0k | 1.7m | 2.6m | 974.0k | 2.1m | 3.2m | 2.1m | ||||
Inventories | (1.2m) | (2.1m) | (2.0m) | 99.0k | (100.0k) | 265.0k | (2.0m) | (4.0m) | (5.6m) | (1.8m) | (1.1m) | (329.0k) | (1.5m) | (4.3m) | (4.3m) | 553.0k | 1.3m | 835.0k | (138.0k) | (504.0k) | (105.0k) | (1.5m) | (3.1m) | (2.7m) | (1.4m) | (3.4m) | (6.0m) | (4.8m) |
Accounts Payable | 22.0k | 452.0k | (109.0k) | (156.0k) | (799.0k) | 451.0k | 1.3m | 1.4m | 4.0m | 2.1m | 467.0k | 2.7m | (18.0k) | (1.1m) | (1.4m) | 257.0k | (1.0m) | 190.0k | 229.0k | (608.0k) | (544.0k) | 2.5m | 1.5m | 1.9m | 2.1m | 5.4m | 2.0m | 2.2m |
USD | Q1, 2012 |
---|---|
Financial Leverage | 2.1 x |
C-
65/100
B
75/100
C
67/100
When was Cardiovascular Systems founded?
Cardiovascular Systems was founded in 1989.
Who are Cardiovascular Systems key executives?
Cardiovascular Systems's key executives are Scott R. Ward, Ryan D. Egeland and Jeff Points.
How many employees does Cardiovascular Systems have?
Cardiovascular Systems has 731 employees.
What is Cardiovascular Systems revenue?
Latest Cardiovascular Systems annual revenue is $236.5 m.
What is Cardiovascular Systems revenue per employee?
Latest Cardiovascular Systems revenue per employee is $323.6 k.
Who are Cardiovascular Systems competitors?
Competitors of Cardiovascular Systems include Flow MedTech, LeMaitre Vascular and Ra Medical Systems.
Where is Cardiovascular Systems headquarters?
Cardiovascular Systems headquarters is located at 1225 Old Hwy 8 NW, Saint Paul.
Where are Cardiovascular Systems offices?
Cardiovascular Systems has offices in Saint Paul and Rochester.
How many offices does Cardiovascular Systems have?
Cardiovascular Systems has 3 offices.
Receive alerts for 300+ data fields across thousands of companies